Article
Nucleic Acid Vaccines against SARS-CoV-2
31 Oct 2022
Abstract excerpt
The coronavirus disease 2019 (COVID-19) has spread worldwide and imposed a substantial burden on human health, the environment, and socioeconomic development, which has also accelerated the process of nucleic acid vaccine development and licensure. Nucleic acid vaccines are viral genetic sequence-based vaccines and third-generation vaccines after whole virus vaccines and recombinant subunit vaccines, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
